These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2111924

  • 1. Intracellular killing of mycobacteria.
    Crowle AJ.
    Res Microbiol; 1990 Feb; 141(2):231-6. PubMed ID: 2111924
    [No Abstract] [Full Text] [Related]

  • 2. Killing intracellular mycobacteria in in vitro macrophage systems: what may be the role of known host microbicidal mechanisms?
    Rastogi N.
    Res Microbiol; 1990 Feb; 141(2):217-30. PubMed ID: 2111923
    [No Abstract] [Full Text] [Related]

  • 3. Sources of variability in assays of the interaction of mycobacteria with mononuclear phagocytes: of mice and men.
    Ellner JJ.
    Res Microbiol; 1990 Feb; 141(2):237-40. PubMed ID: 2111925
    [No Abstract] [Full Text] [Related]

  • 4. Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium.
    Crowle AJ, Cohn DL, Poche P.
    Infect Immun; 1989 May; 57(5):1445-51. PubMed ID: 2496029
    [Abstract] [Full Text] [Related]

  • 5. Immunity to mycobacteria.
    Orme IM.
    Curr Opin Immunol; 1993 Aug; 5(4):497-502. PubMed ID: 8216924
    [Abstract] [Full Text] [Related]

  • 6. Immunological defense mechanisms in tuberculosis and MAC-infection.
    Hartmann P, Plum G.
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):147-52. PubMed ID: 10354865
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Slowly growing mycobacteria and chronic skin disorders.
    Mattila JO, Katila ML, Vornanen M.
    Clin Infect Dis; 1996 Nov; 23(5):1043-8. PubMed ID: 8922800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serological analysis of C-terminal region of alpha antigen from Mycobacterium avium-intracellulare complex and Mycobacterium tuberculosis.
    Kitaura H, Ohara N, Naito M, Kobayashi K, Yamada T.
    APMIS; 1998 Sep; 106(9):893-900. PubMed ID: 9808416
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines.
    Bermudez LE, Young LS.
    Res Microbiol; 1990 Feb; 141(2):241-3. PubMed ID: 2189170
    [No Abstract] [Full Text] [Related]

  • 16. Late acquisition of hyporesponsiveness to lipopolysaccharide by Mycobacterium avium-infected human macrophages in producing tumor necrosis factor-alpha but not interleukin-1 beta and -6.
    Fattorini L, Xiao Y, Ausiello CM, Urbani F, laSala A, Mattei M, Orefici G.
    J Infect Dis; 1996 Apr; 173(4):1030-4. PubMed ID: 8603946
    [Abstract] [Full Text] [Related]

  • 17. Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.
    Bermudez LE, Parker A, Goodman JR.
    Infect Immun; 1997 May; 65(5):1916-25. PubMed ID: 9125580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.